A. V. Hoffbrand

13.0k total citations
272 papers, 10.2k citations indexed

About

A. V. Hoffbrand is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, A. V. Hoffbrand has authored 272 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Hematology, 110 papers in Genetics and 80 papers in Molecular Biology. Recurrent topics in A. V. Hoffbrand's work include Chronic Lymphocytic Leukemia Research (52 papers), Hemoglobinopathies and Related Disorders (49 papers) and Iron Metabolism and Disorders (42 papers). A. V. Hoffbrand is often cited by papers focused on Chronic Lymphocytic Leukemia Research (52 papers), Hemoglobinopathies and Related Disorders (49 papers) and Iron Metabolism and Disorders (42 papers). A. V. Hoffbrand collaborates with scholars based in United Kingdom, United States and Canada. A. V. Hoffbrand's co-authors include B. Wonke, K. Ganeshaguru, H. G. Prentice, George Janossy, R. Gitendra Wickremasinghe, Malcolm K. Brenner, F. N. Al‐Refaie, George J. Kontoghiorghes, L Sheppard and H. G. Prentice and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

A. V. Hoffbrand

268 papers receiving 9.5k citations

Peers

A. V. Hoffbrand

HEMAT

GENET

IMMUN

ONCOL

Karl G. Blume United States

Kazuma Ohyashiki Japan

Gary J. Schiller United States

Richard J. Jones United States

Edo Vellenga Netherlands

Janice Gabrilove United States

Keith R. McCrae United States

Rajesh Chopra United Kingdom

Shinichiro Okamoto Japan

Robert A. Brodsky United States

Karl G. Blume United States

A. V. Hoffbrand

6.7k ×1.4

HEMAT

1.8k ×0.4

GENET

3.4k ×1.4

IMMUN

1.2k ×0.6

2.8k ×2.0

ONCOL

Citations per year, relative to A. V. Hoffbrand A. V. Hoffbrand (= 1×) peers Karl G. Blume

Countries citing papers authored by A. V. Hoffbrand

Since Specialization

Citations

This map shows the geographic impact of A. V. Hoffbrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Hoffbrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Hoffbrand more than expected).

Fields of papers citing papers by A. V. Hoffbrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Hoffbrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Hoffbrand. The network helps show where A. V. Hoffbrand may publish in the future.

Co-authorship network of co-authors of A. V. Hoffbrand

This figure shows the co-authorship network connecting the top 25 collaborators of A. V. Hoffbrand. A scholar is included among the top collaborators of A. V. Hoffbrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. V. Hoffbrand. A. V. Hoffbrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoffbrand, A. V.. (2025). Megaloblastic anaemia. PubMed. 92-93. 201–221.

Howard, Jo, A. V. Hoffbrand, H. G. Prentice, & Atul Mehta. (2002). Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura. British Journal of Haematology. 117(3). 712–715. 122 indexed citations

Deane, Miriam, Mickey Koh, Letizia Foroni, et al.. (1998). FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission. Bone Marrow Transplantation. 22(12). 1137–1143. 19 indexed citations

Foroni, Letizia, Mary Papaioannou, Paul Cannell, et al.. (1997). Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response. Leukemia. 11(10). 1732–1741. 60 indexed citations

Collins, Peter W., et al.. (1995). Induction of tissue factor expression in human monocyte/endothelium cocultures. British Journal of Haematology. 91(4). 963–970. 53 indexed citations

Rule, Simon, et al.. (1994). Serum vitamin B₁₂ and transcobalamin levels in early HIV disease. American Journal of Hematology. 47(3). 167–171. 24 indexed citations

Cunningham, John M., F. N. Al‐Refaie, Ann E. Hunter, L Sheppard, & A. V. Hoffbrand. (1994). Differential toxicity of α‐keto hydroxypyridine iron chelators and desferrioxamine to human haemopoietic precursors in vitro. European Journal Of Haematology. 52(3). 176–179. 19 indexed citations

İkincioğulları, Aydan, et al.. (1992). Activation marker expression on the peripheral blood lymphocytes of normal volunteers, recipients of Interleukin 2 and patients undergoing bone marrow transplantation. Experimental Hematology. 20. 819–819. 2 indexed citations

Heslop, Helen E., et al.. (1990). Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.. The Journal of Experimental Medicine. 172(6). 1729–1734. 66 indexed citations

10.

Yacoub, M, et al.. (1990). CARDIAC TRANSPLANTATION FOR DOXORUBICIN‐INDUCED CARDIOMYOPATHY IN ACUTE MYELOID LEUKAEMIA. British Journal of Haematology. 74(4). 541–541. 7 indexed citations

11.

Kontoghiorghes, George J., A Bartlett, A. V. Hoffbrand, et al.. (1990). Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L₁) I. IRON CHELATION AND METABOLIC STUDIES. British Journal of Haematology. 76(2). 295–300. 109 indexed citations

12.

Bartlett, A, A. V. Hoffbrand, & George J. Kontoghiorghes. (1990). Long‐term trial with the oral iron chelator 1,2‐dimethy1‐3‐hydroxypyrid‐4‐one (L₁) II. CLINICAL OBSERVATIONS. British Journal of Haematology. 76(2). 301–304. 77 indexed citations

13.

Drexler, Hans G., Suzanne M. Gignac, A. V. Hoffbrand, & Jun Minowada. (1989). Formation of multinucleated cells in a Hodgkin's‐disease‐derived cell line. International Journal of Cancer. 43(6). 1083–1090. 45 indexed citations

14.

Ganeshaguru, K., A. Piga, Luciano Latini, & A. V. Hoffbrand. (1989). Inability of Poly-ADP-Ribosylation Inhibitors to Protect Peripheral Blood Lymphocytes from the Toxic Effects of ADA Inhibition. Advances in experimental medicine and biology. 253B. 251–258. 3 indexed citations

15.

Lyttelton, M. P. A., Peter Browett, Malcolm K. Brenner, et al.. (1988). Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation.. PubMed. 3(6). 641–6. 4 indexed citations

16.

Wickremasinghe, R. Gitendra, et al.. (1986). PHYTOHEMAGGLUTININ (PHA)-STIMULATED HUMAN LYMPHOCYTES-T UNDERGO ONE ROUND OF DNA-SYNTHESIS AND CELL-DIVISION WITHOUT A REQUIREMENT FOR INTERLEUKIN-2 (IL-2). UCL Discovery (University College London). 1 indexed citations

17.

Chiu, Hsien‐Yi, et al.. (1986). Infection with Yersinia enterocolitica in patients with iron overload.. BMJ. 292(6513). 97.1–97. 33 indexed citations

18.

Hann, Ian, H. G. Prentice, Hilary Blacklock, et al.. (1983). Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.. BMJ. 287(6389). 384–388. 106 indexed citations

19.

Hoffbrand, A. V., et al.. (1981). METABOLISM OF DEOXYURIDINE-DERIVED NUCLEOTIDES BY MEGALOBLASTIC MARROW-CELLS. UCL Discovery (University College London). 1 indexed citations

20.

Catovsky, Daniel, Sally M. Pittman, Maureen M. O’Brien, et al.. (1979). Multiparameter studies in lymphoid leukemias.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(4 Suppl). 736–45. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact